Request for Samples and Protocols

ICR 201207-0910-005

OMB: 0910-0206

Federal Form Document

Forms and Documents
Document
Name
Status
Supporting Statement A
2012-06-29
ICR Details
0910-0206 201207-0910-005
Historical Active 200908-0910-001
HHS/FDA
Request for Samples and Protocols
Extension without change of a currently approved collection   No
Regular
Approved without change 11/26/2012
Retrieve Notice of Action (NOA) 07/17/2012
  Inventory as of this Action Requested Previously Approved
11/30/2015 36 Months From Approved 11/30/2012
6,827 0 6,314
20,572 0 19,155
0 0 0

FDA may at any time require manufacturers of licensed biological products to submit to FDA samples of any lot with the protocols showing the results of the applicable tests prior to distributing the lot of the product. Samples and protocols are required by FDA to help ensure the safety, purity and potency of the product because of thdue to the potential of lot-to-lot variability of a product produced from living organisms.

US Code: 42 USC 262 Name of Law: Public Health Service Act
  
None

Not associated with rulemaking

  77 FR 9663 02/17/2012
77 FR 41408 07/13/2012
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 6,827 6,314 0 0 513 0
Annual Time Burden (Hours) 20,572 19,155 0 0 1,417 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No

$1,024,050
No
No
No
No
No
Uncollected
ILa Mizrachi 301 796-7726 ila.mizrachi@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
07/17/2012


© 2024 OMB.report | Privacy Policy